The World's First AI-Powered Image-Guided Wound Healing System — integrating real-time bacterial immune suppression detection, wound pH monitoring, cardiovascular risk assessment, multi-modal imaging, and AI analytics to transform wound care into wound healing.
Traditional wound care often focuses on maintaining wounds in a chronic state. Our AI-Powered Image-Guided approach fundamentally shifts to active, data-driven healing — integrating real-time bacterial immune suppression detection, wound pH monitoring, vascular assessment, and AI analytics to treat the root causes of non-healing, not just the symptoms.
Significantly increase wound closure rates and reduce time to heal
Decrease infections, hospitalizations, and amputations through early intervention
Streamline diagnostic and documentation workflows
Extend specialist-level care via telehealth and mobile platforms

A comprehensive ecosystem for assessment, treatment, and monitoring that transforms wound care from reactive to proactive—spanning surgical, traumatic, and chronic wounds across all care settings.
Non-invasive PAD diagnosis with MESI mTABLET (ABI/TBI) and 80 Beats VICORDER for comprehensive vascular analysis.
3D morphology, thermal imaging, and fluorescence detection with MIIS MPD100 for comprehensive wound characterization.
Automated measurement, healing trajectory prediction, and clinical decision support via eKare platform.
Remote specialist consultation, mobile wound monitoring, and patient engagement through integrated platforms.
CureVision BacteriaScan uses real-time porphyrin fluorescence to detect bacterial contamination before clinical signs appear. New research (Cell Host & Microbe, 2026) shows E. faecalis produces lactic acid that shuts down macrophage NF-κB signalling—suppressing the immune system and creating polymicrobial infections. Early fluorescence detection is the critical intervention window before immune paralysis is established. EVOSens pH sensor dressing provides continuous wound pH monitoring: alkaline shift (pH >7) signals active immune suppression and triggers escalation.
Comprehensive cardiovascular screening to identify risk factors that impact wound healing. MESI mTABLET provides rapid ABI/TBI and ECG, while 80 Beats VICORDER adds advanced arterial stiffness, central blood pressure, and endothelial function testing for complete cardiovascular profiling.
FDA-approved Numobag® delivers Topical Hyperbaric Oxygen Therapy (THOT®) at 1.03–1.05 ATA — portable, disposable, and deployable anywhere with only an oxygen source. Combined with Vaporox VHT, ultrasonic debridement, and the full IMBED Bio SAM™ antimicrobial matrix suite for comprehensive wound healing.
Every treatment decision guided by objective, multi-modal data that continuously adapts based on patient response.
View Risk-Stratified Care Delivery ModelCardiovascular Risk Screening: MESI mTABLET performs rapid ABI/TBI and 12-lead ECG, while 80 Beats VICORDER measures arterial stiffness (PWV), central blood pressure, and endothelial function—identifying cardiovascular disease risk that directly impacts healing.
Wound Characterization: Baseline wound imaging (MIIS MPD100) and CureVision BacteriaScan fluorescence detection establish healing potential and infection risk. EVOSens pH sensor dressing applied for continuous pH monitoring — alkaline shift (pH >7) triggers immediate escalation as it signals active immune suppression by lactic acid-producing bacteria (Cell Host & Microbe, 2026).
Perfusion-Guided: PAD detection triggers immediate vascular referral.
Bioburden-Guided: CureVision BacteriaScan directs Debriflo ultrasonic irrigation to bacterial hotspots.
Wound Sealing: Altrazeal transforming powder creates 30-day protective barrier after bacterial clearance.
Oxygen-Guided: Vaporox VHT and Numobag® THOT® therapy penetrate oxygen-permeable Altrazeal film for accelerated healing.
Weekly imaging tracks wound dimensions, tissue composition, and thermal gradients. Machine learning predicts healing trajectory and triggers alerts for clinical re-evaluation.
HIPAA-compliant cloud platform enables remote specialist review, expert consultation, and patient engagement through mobile apps.

HealPath360 treats all wound types—from diabetic ulcers to atypical wounds like pyoderma gangrenosum and radiation injuries. Select your wound category to see customized technology recommendations.
Select your wound type to receive personalized technology recommendations from the HealPath360 platform
Real-world evidence from forward-thinking providers demonstrates the transformative impact of image-guided wound care.
Wound Care Plus clinical data with integrated imaging and diagnostics
vs. 30.9% with standard care alone in chronic diabetic foot ulcers
Through fluorescence-guided bioburden detection and targeted debridement
As demonstrated by Wound Care Plus, the integration of advanced imaging and diagnostics leads to demonstrably better outcomes: fewer infections, reduced antibiotic use, and faster healing times. Their mobile wound clinic model proves that specialist-level care can be delivered anywhere with the right technology infrastructure.
Join forward-thinking providers who are shifting from chronic wound maintenance to active, predictable, and personalized healing.